A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma

16Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive malignant tumour associated with asbestos exposure that has only a limited response to conventional therapy; therefore, diagnosing MPM early is very important. We have previously reported that angiopoietin (Ang)-1 was correlated with bleomycin-induced pulmonary fibrosis. Here, we investigated the association of Ang-1 with the development of MPM cells, which originate from mesenchymal cells similar to lung fibroblasts, and demonstrated that Ang-1 stimulated the growth and migration of MPM cells in vitro. We also demonstrated that patients with MPM had significantly higher serum levels of Ang-1 in comparison to a population who had been exposed to asbestos but had not developed MPM. The patients with advanced-stage MPM showed higher levels of Ang-1 than the early-stage MPM patients and the Kaplan-Meier method revealed a significant correlation between serum Ang-1 levels and survival. We propose the possibility that Ang-1 plays an important role in MPM tumour growth and our data suggest that the serum concentration of Ang-1 could be useful as prognostic factor. Copyright©ERS 2010.

Author supplied keywords

Cite

CITATION STYLE

APA

Tabata, C., Hirayama, N., Tabata, R., Yasumitsu, A., Yamada, S., Murakami, A., … Nakano, T. (2010). A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma. European Respiratory Journal, 36(5), 1099–1105. https://doi.org/10.1183/09031936.00154009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free